I. Zubina,Vladimir Sharoyko,Vladimir Dobronravov,Airat Sadykov,O. Beresneva,E. Bogdanova
Abstract:Patients with CKD have significantly increased cardiovascular risk, and heart failure is a leading cause of morbidity and mortality in these patients. Myocardial hypertrophy is a hallmark of cardiac remodeling and dysfunction in CKD and is known to be mediated by angiotensin II, catecholamines, hyperphosphatemia, hyperparathyroidism, increase in FGF23, decrease in Klotho and alterations in various signaling pathways including calcineurin, mitogen-activated protein kinase ERK1/2, calmodulin-dependent protein kinase II etc. Less well understood are the mechanisms of fibrosis and intramyocardial arterial remodeling in CKD, which may be related to hyperphosphatemia and decreased renal and systemic Klotho. The aim of this study was to evaluate the molecular and cellular features of myocardial remodeling in experimental mild CKD.
We induced CKD by 3/4 nephrectomy (Nx) in adult male spontaneously hypertensive rats (SHR) with a follow-up period of 4 months. Animals were fed standard chow containing 0.6% phosphate. Sham-operated Wistar rats and SHR served as controls. We measured serum creatinine, renal interstitial fibrosis area, systolic blood pressure (BP), myocardial mass index (MMI), histological indices of myocardial hypertrophy, interstitial fibrosis and intramyocardial artery (IA) remodeling (H&E, Masson's trichrome, von Kossa stain), myocardial phosphorus content, serum levels of inorganic phosphate (Pi), PTH and FGF23. Myocardial expression of phosphate transporters PiT1, ERK1/2, WNT, BMP, Notch, Hedgehog signaling pathways and LRG4 molecules was evaluated by PCR-RT, IHC and IF (Zeiss LSM 710; study performed at the Centre for Collective Use “Confocal Microscopy” of the Pavlov Institute of Physiology, Russian Academy of Sciences).
Chronic kidney injury and phosphate regulatory factors did not differ, whereas BP and MMI were higher in sham SHR vs. Wistar rats (Fig. 1). Nx rats showed features of mild chronic kidney injury before the elevation of serum PTH, FGF23 levels (Fig. 1). Myocardial P content and serum Pi were higher in Nx and in the combined SHR group and directly correlated with indices of IA remodeling. Cardiomyocyte diameter, myocardial interstitial and perivascular fibrosis were higher in Nx (Figs 1, 2a) and accompanied with upregulation in Ppp3ca mRNA (calcineurin A, Fig. 2b), Mapk1 mRNA (ERK2, Fig. 2b), phospho-ERK1/2 (Figs 1, 3), PiT1 (Figs 1, 2c), Lgr4 (Fig. 2c) and downregulation of Hes1 mRNA (Fig. 2b). PiT1 and pospho-ERK1/2 were co-expressed in IA media from SHR (Fig. 2c). In Nx, nestin and LGR4 were expressed by IA adventitia and media cells, myocardial interstitial cells, and occasionally co-localized (Fig. 2c). Hes1 expression was detected in IA and capillary endothelial cells and co-localised with Gli1 in IA media; Gli1 was also detected in cardiomyocyte nuclei (Fig. 2c). In SHR, beta-catenin expression in cardiomyocytes was more pronounced in Nx (Fig. 2c).
Mild CKD is associated with histological and molecular features of cardiomyocyte hypertrophy, myocardial fibrosis and intramyocardial arterial remodeling, which are probably modulated by phosphate redistribution and its tissue retention involving upregulation of PiT1 and ERK1/2, as well as alterations in signals related to progenitor regulation and myocyte hypertrophy.
What problem does this paper attempt to address?
The paper aims to explore the molecular and cellular characteristics of myocardial remodeling under mild chronic kidney disease (CKD) conditions. Specifically, the study focuses on the following aspects:
1. **Background and Objectives**: Cardiovascular risk is significantly increased in patients with chronic kidney disease, and heart failure is the main cause of morbidity and mortality in these patients. Myocardial hypertrophy is a hallmark of cardiac remodeling and dysfunction in CKD and is known to be mediated by various factors such as angiotensin II, catecholamines, hyperphosphatemia, secondary hyperparathyroidism, elevated FGF23, and reduced Klotho. However, the specific mechanisms of fibrosis and intracardiac arterial remodeling in CKD are not fully understood and may be related to hyperphosphatemia and decreased renal Klotho levels.
2. **Research Methods**: CKD was induced in adult spontaneously hypertensive rats (SHR) by 3/4 nephrectomy (Nx) and followed up for 4 months. Control groups included sham-operated Wistar rats and SHR rats. Serum creatinine, renal interstitial fibrosis area, systolic blood pressure (BP), myocardial mass index (MMI), myocardial hypertrophy, interstitial fibrosis, and intracardiac arterial (IA) remodeling histological indicators, myocardial phosphorus content, and serum inorganic phosphate (Pi), PTH, and FGF23 levels were measured. The expression of phosphate transporter PiT1, ERK1/2, Wnt, BMP, Notch, Hedgehog signaling pathways, and LRG4 molecules in the myocardium was assessed by PCR-RT, immunohistochemistry (IHC), and immunofluorescence (IF).
3. **Results**: There were no differences in chronic kidney injury and phosphate regulatory factors between the groups, but blood pressure (BP) and myocardial mass index (MMI) were higher in the sham-operated SHR group than in Wistar rats. Nephrectomized rats exhibited characteristics of mild chronic kidney injury before the elevation of PTH and FGF23 levels. Myocardial phosphorus content and serum Pi were higher in the nephrectomized and combined SHR groups and were directly related to IA remodeling indices. Cardiomyocyte diameter, myocardial interstitial, and perivascular fibrosis were higher in the nephrectomized group, accompanied by upregulation of Ppp3ca mRNA (calcineurin A), Mapk1 mRNA (ERK2), phosphorylated ERK1/2, PiT1, Lgr4, and downregulation of Hes1 mRNA.
4. **Conclusion**: Mild CKD is associated with histological and molecular features of cardiomyocyte hypertrophy, myocardial fibrosis, and intracardiac arterial remodeling, which may be caused by phosphate redistribution and its tissue retention, involving upregulation of PiT1 and ERK1/2 and signaling changes related to progenitor cell regulation and cardiomyocyte hypertrophy.